We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PXD
251
DELISTED
Pioneer Natural Resource Co.
PXD
$4.49M 0.1%
20,131
+5,964
+42% +$1.51M
INTU icon
252
Intuit
INTU
$88.1B
$4.47M 0.1%
11,601
+364
+3% +$151K
JPST icon
253
JPMorgan Ultra-Short Income ETF
JPST
$40.3B
$4.46M 0.1%
89,092
+1,974
+2% +$99K
SUB icon
254
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$4.4M 0.09%
42,079
-13,708
-25% -$1.43M
VRTX icon
255
Vertex Pharmaceuticals
VRTX
$120B
$4.38M 0.09%
15,542
+972
+7% +$260K
FCX icon
256
Freeport-McMoran
FCX
$90.6B
$4.38M 0.09%
149,518
-11,855
-7% -$475K
DBA icon
257
Invesco DB Agriculture Fund
DBA
$1.24B
$4.37M 0.09%
214,631
+22,003
+11% +$484K
BN icon
258
Brookfield
BN
$106B
$4.37M 0.09%
182,488
-23,671
-11% -$633K
KMB icon
259
Kimberly-Clark
KMB
$36.6B
$4.36M 0.09%
32,286
-3,561
-10% -$469K
IWD icon
260
iShares Russell 1000 Value ETF
IWD
$82.4B
$4.35M 0.09%
30,023
+4,026
+15% +$630K
EW icon
261
Edwards Lifesciences
EW
$50.8B
$4.31M 0.09%
45,333
+2,202
+5% +$228K
SYK icon
262
Stryker
SYK
$129B
$4.27M 0.09%
21,479
-998
-4% -$234K
PARA
263
DELISTED
Paramount Global Class B
PARA
$4.27M 0.09%
173,084
-2,439
-1% -$74.3K
RSP icon
264
Invesco S&P 500 Equal Weight ETF
RSP
$97.8B
$4.26M 0.09%
31,722
-8,225
-21% -$1.2M
FTSL icon
265
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$4.24M 0.09%
96,213
+6,381
+7% +$294K
VEA icon
266
Vanguard FTSE Developed Markets ETF
VEA
$229B
$4.21M 0.09%
103,219
+6,272
+6% +$279K
AR icon
267
Antero Resources
AR
$11.1B
$4.16M 0.09%
135,700
-40,924
-23% -$1.5M
ADM icon
268
Archer Daniels Midland
ADM
$37.8B
$4.09M 0.09%
52,710
-14,054
-21% -$1.23M
DIA icon
269
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.6B
$4.08M 0.09%
13,265
+1,030
+8% +$337K
NSC icon
270
Norfolk Southern
NSC
$75.3B
$4.08M 0.09%
17,929
-314
-2% -$77.1K
MAG
271
DELISTED
MAG Silver
MAG
$4.07M 0.09%
334,120
+1,171
+0.4% +$17.1K
SNA icon
272
Snap-on
SNA
$21.3B
$4.05M 0.09%
20,547
+345
+2% +$73.5K
ITM icon
273
VanEck Intermediate Muni ETF
ITM
$2.14B
$4M 0.09%
87,611
+4,408
+5% +$201K
EXPD icon
274
Expeditors International
EXPD
$22B
$4M 0.09%
41,042
-1,341
-3% -$137K
SPYV icon
275
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.3B
$3.99M 0.09%
108,263
+89,671
+482% +$3.55M

Similar funds

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.